Intervention effect of PI3Ky Inhibitor AS605240 on autoimmune myocarditis in mice

Journal of Sichuan University (Medical Science)

Volumn 40, Issue 5, 2009, Pages

  Jin, Ke ^a   Song, Li Fang ^a   He, Chun Mei ^a   Wang, Zhen Ling ^a   Hu, Xiao Hong ^a   Wu, Xiao Hua ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Macrophage; MCP 1; PI3Ky; TNF Myocarditis

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 5 QUINOXALIN 6 YLMETHYLENETHIAZOLIDINE 2,4 DIONE; 5-QUINOXALIN-6-YLMETHYLENETHIAZOLIDINE-2,4-DIONE; ISOENZYME; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE GAMMA; PHOSPHATIDYLINOSITOL 3-KINASE GAMMA; QUINOXALINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; AUTOIMMUNE DISEASE; BAGG ALBINO MOUSE; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; MALE; METABOLISM; MOUSE; MYOCARDITIS; RANDOMIZATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; AUTOIMMUNE DISEASES; CHEMOKINE CCL2; DOWN-REGULATION; ISOENZYMES; MALE; MICE; MICE, INBRED BALB C; MYOCARDITIS; QUINOXALINES; RANDOM ALLOCATION; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349745617     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Pisan! B, Taylor DO, Mason JW. Inflammatory myocardial diseases and cardiomyopathies. Am J Med, 1997,102(5),459-469.
2. Sasaki T, Irie-Sasaki J, Russell GJ, et al. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science,2000,287(5455), 1040-1046.
3. Hirsch E, Katanaev VL, Garlanda C, et al. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science,2000,287(5455) ,1049-1053.
4. Pummerer CL, Luze K, Grassl G, et al. Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice. J Clin Invest, 1996,97(9)12057-2062.
5. Camps M, Ruckle T, Ji H, et al. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med,2005,11(9) s936-943.
6. Liu WR, Nakamura H, Shioji K, et al. Thioredoxin-1 ameliorates myosin-induced autoimmune myocarditis by suppressing chemokine expressions and leukocyte chemotaxis in mice. Circulation,2004, 110(10), 1276-1283.
7. Katso R, Okkenhaug K, Ahmadi K, et al. Cellular function of phosphoinositide3-kinases, implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol, 2001,17,615-675.
8. RUckle T, Schwarz MK, Rommel C. PI3Kgamma inhibitioni towards an "aspirin of the 21st century"? Nat Rev Drug Discov,2006,5(11) ,903-918.
9. Barber DF, BartolomS A, Hernandez C, et al. PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nat Med,2005,11 (9), 933-935.
10. Fougerat A, Gayral S, Gourdy P, et al. Genetic and pharmacological targeting of phosphoinositide 3-kinase-y reduces atherosclerosis and favors plaque stability by modulating inflammatory processes. Circulation, 2008, 117 (10),1310-1317.
11. Goser S, Ottl R, Brodner A, et al. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-lei in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy. Circulation,2005,112(22) ,3400-3407.
12. Lenzo JC, Fairweather D, Shellam GR, et al. Immunomodulation of murine cytomegalovirus-induced myocarditis in mice treated with lipopolysaccharide and tumor necrosis factor. Cell Immunol,2001,213(1) ,52-61.
13. Sack M. Tumor necrosis factor-alpha in cardiovascular biology and thepotential role for anti-tumor necrosis factor-alpha therapy in heartdisease. Pharmacol Ther, 2002,94 (1-2) , 123-135.